Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

5-HT1A receptor and Lurasidone

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between 5-HT1A receptor and Lurasidone

5-HT1A receptor vs. Lurasidone

The serotonin 1A receptor (or 5-HT1A receptor) is a subtype of serotonin receptor (5-HT receptor) that binds the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT). Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma and marketed by Sunovion in the U.S. It has been an FDA approved treatment for schizophrenia since 2010 and for treating depressive episodes in adults with bipolar I disorder since 2013.

Similarities between 5-HT1A receptor and Lurasidone

5-HT1A receptor and Lurasidone have 17 things in common (in Unionpedia): Aripiprazole, Asenapine, Atypical antipsychotic, Clozapine, Haloperidol, Learning, Memory, Olanzapine, Partial agonist, Perospirone, Quetiapine, Receptor antagonist, Risperidone, Schizophrenia, Ziprasidone, 5-HT receptor, 5-HT7 receptor.

Aripiprazole

Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is recommended and primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism. According to a Cochrane review, evidence for the oral form in schizophrenia is not sufficient to determine effects on general functioning. Additionally, because many people dropped out of the medication trials before they were completed, the overall strength of the conclusions is low. Side effects include neuroleptic malignant syndrome, a movement disorder known as tardive dyskinesia, and high blood sugar in those with diabetes. In the elderly there is an increased risk of death. It is thus not recommended for use in those with psychosis due to dementia. It is pregnancy category C in the United States and category C in Australia, meaning there is possible evidence of harm to the fetus. It is not recommended for women who are breastfeeding. It is unclear whether it is safe or effective in people less than 18 years old. It is a partial dopamine agonist. Aripiprazole was developed by Otsuka in Japan. In the United States, Otsuka America markets it jointly with Bristol-Myers Squibb. From April 2013 to March 2014, sales of Abilify amounted to almost $6.9 billion.

5-HT1A receptor and Aripiprazole · Aripiprazole and Lurasidone · See more »

Asenapine

Asenapine, sold under the trade names Saphris and Sycrest among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder.

5-HT1A receptor and Asenapine · Asenapine and Lurasidone · See more »

Atypical antipsychotic

The atypical antipsychotics (AAP; also known as second generation antipsychotics (SGAs)) are a group of antipsychotic drugs (antipsychotic drugs in general are also known as major tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) used to treat psychiatric conditions.

5-HT1A receptor and Atypical antipsychotic · Atypical antipsychotic and Lurasidone · See more »

Clozapine

Clozapine, sold under the brand name Clozaril among others, is an atypical antipsychotic medication.

5-HT1A receptor and Clozapine · Clozapine and Lurasidone · See more »

Haloperidol

Haloperidol, marketed under the trade name Haldol among others, is a typical antipsychotic medication.

5-HT1A receptor and Haloperidol · Haloperidol and Lurasidone · See more »

Learning

Learning is the process of acquiring new or modifying existing knowledge, behaviors, skills, values, or preferences.

5-HT1A receptor and Learning · Learning and Lurasidone · See more »

Memory

Memory is the faculty of the mind by which information is encoded, stored, and retrieved.

5-HT1A receptor and Memory · Lurasidone and Memory · See more »

Olanzapine

Olanzapine (originally branded Zyprexa) is an antipsychotic medication used to treat schizophrenia and bipolar disorder.

5-HT1A receptor and Olanzapine · Lurasidone and Olanzapine · See more »

Partial agonist

In pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist.

5-HT1A receptor and Partial agonist · Lurasidone and Partial agonist · See more »

Perospirone

Perospirone (Lullan) is an atypical antipsychotic of the azapirone family.

5-HT1A receptor and Perospirone · Lurasidone and Perospirone · See more »

Quetiapine

Quetiapine, marketed as Seroquel among other names, is an atypical antipsychotic used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder.

5-HT1A receptor and Quetiapine · Lurasidone and Quetiapine · See more »

Receptor antagonist

A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.

5-HT1A receptor and Receptor antagonist · Lurasidone and Receptor antagonist · See more »

Risperidone

Risperidone, sold under the trade name Risperdal among others, is an antipsychotic medication.

5-HT1A receptor and Risperidone · Lurasidone and Risperidone · See more »

Schizophrenia

Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality.

5-HT1A receptor and Schizophrenia · Lurasidone and Schizophrenia · See more »

Ziprasidone

Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic which is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder.

5-HT1A receptor and Ziprasidone · Lurasidone and Ziprasidone · See more »

5-HT receptor

5-hydroxytryptamine receptors or 5-HT receptors, or serotonin receptors, are a group of G protein-coupled receptor and ligand-gated ion channels found in the central and peripheral nervous systems.

5-HT receptor and 5-HT1A receptor · 5-HT receptor and Lurasidone · See more »

5-HT7 receptor

The 5-HT7 receptor is a member of the GPCR superfamily of cell surface receptors and is activated by the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) The 5-HT7 receptor is coupled to Gs (stimulates the production of the intracellular signaling molecule cAMP) and is expressed in a variety of human tissues, particularly in the brain, the gastrointestinal tract, and in various blood vessels.

5-HT1A receptor and 5-HT7 receptor · 5-HT7 receptor and Lurasidone · See more »

The list above answers the following questions

5-HT1A receptor and Lurasidone Comparison

5-HT1A receptor has 263 relations, while Lurasidone has 104. As they have in common 17, the Jaccard index is 4.63% = 17 / (263 + 104).

References

This article shows the relationship between 5-HT1A receptor and Lurasidone. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »